Human Apolipoprotein B-100 Protein
520€ (1 mg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Human Apolipoprotein B-100 Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx060870
Description
Human Apolipoprotein B-100 Protein is a lipoprotein purified from Human Plasma.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Human Apolipo B-100 |
| Host | Human |
| Origin | Human |
| Conjugation | Unconjugated |
| Observed MW | Concentration: 1 mg/ml |
| Purity | Does not contain Apo(a), Apo C or Apo E proteins. |
| Purification | Purified by: (1) Ultracentrifugation at d 1.03-1.05, (2) Delipidation with diethyl ether:ethanol (3:1), and (3)Gel filtration over Sephacryl S-200. |
| Size 1 | 1 mg |
| Form | Liquid |
| Buffer | 10 mM Tris-Buffered Saline, pH 7.4, containing 10 mM Sodium Decyl Sulfate. Does not contain preservatives. |
| Availability | Please enquire. |
| Storage | Store at 2-8 °C. Do not freeze. |
| Dry Ice | No |
| Alias | APOB, FLDB, LDLCQ4, apoB-100,apolipoprotein B, FCHL2 |
| Background | Protein APOB |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
APOB is a major structural protein of low-density lipoproteins (LDL), very-low-density lipoproteins (VLDL), and chylomicrons, which are essential for lipid transport and metabolism in the body It exists in two primary isoforms: APOB-100, produced in the liver, and APOB-48, synthesized in the intestine APOB-100 is critical for the assembly and secretion of VLDL and LDL particles, facilitating the transport of cholesterol and triglycerides to peripheral tissues via binding to the LDL receptor (LDLR) Mutations or overexpression of APOB contribute to familial hypercholesterolemia and other dyslipidemias, leading to elevated LDL cholesterol levels and increased risk of atherosclerosis and cardiovascular diseases APOB-48, on the other hand, plays a key role in chylomicron formation and dietary fat absorption Genetic variations in the APOB gene have been linked to metabolic disorders, including obesity, diabetes, and fatty liver disease APOB levels serve as a marker of cardiovascular risk, with elevated concentrations indicating higher susceptibility to coronary artery disease Therapies targeting APOB, such as antisense oligonucleotides or LDL-lowering drugs like statins, have shown significant success in reducing cardiovascular events APOB remains a key focus in lipid biology due to its central role in lipid transport and cardiovascular health
Related Products
Bovine ApoB100 (Apolipoprotein B100) ELISA Kit
Ver Producto
Human ApoB100 (Apolipoprotein B100) ELISA Kit
Ver Producto